INCYTE CORP |
||
| Route 141 & Henry Clay Rd, Bldg E336 | Ticker: | INCY |
| Wilmington , DE 19804 | Exchange: | NASD |
| 302-498-6700 | Sector: | Health Care |
| Industry: | Biotechnology | |
| Complete Financials: Q2Y08 | Currency: USD | Current Annual Period: Y07 |
|---|---|---|
| Business Summary INCY Incyte Corporation operates as a drug discovery and development company, which focuses on developing proprietary small molecule drugs to treat human immunodeficiency virus (HIV), diabetes, oncology, and inflammation diseases. |
||
| Price
52 Week High 52 Week Low 3 Month Avg Daily Vol (Mil) 10 Day Avg Daily Vol (Mil) Beta Indicated Annual Dividend Dividend Yield % |
4.630 12.830 4.620 1.208 1.624 2.148 0.000 0.000 |
Price/Sales (TTM)
P/E Ratio (TTM) Price/Book (MRQ) Price/Cash Flow (TTM) Return on Assets (TTM) % Return on Equity (TTM) % Current Ratio (MRQ) Total Debt/Equity (MRQ) |
21.435 NC -3.080 2.115 -52.800 71.823 4.659 -1.650 |
| Note:
Mil = Millions MRQ = Most Recent Quarter TTM = Trailing Twelve Months |
| SHARE RELATED INFORMATION | SHORT INTEREST INFORMATION | |||
|---|---|---|---|---|
| Market Cap (Mil)
Shares Outstanding (Mil) Float (Mil) |
442.119 95.490 55.961 |
Current Month (Mil)
Previous Month (Mil) Short Interest Ratio (Days) |
15.689 16.506 NA |
|
| INSTITUTIONAL &
INSIDER OWNERSHIP |
PURCHASES
(Mil) |
SALES
(Mil) |
NET PURCHASES
(Mil) |
PERCENT
OWNED (%) |
PREVIOUS PERCENT
OWNED (%) |
|---|---|---|---|---|---|
| Institutions (3 Months)
Insiders (6 Months) |
7.474 1.100 |
-9.685 0.000 |
-2.211 1.100 |
103.704 21.928 |
106.777 NA |
| GROWTH RATES | 1 YEAR | 3 YEAR | 5 YEAR |
|---|---|---|---|
| Sales %
EPS % Dividend % |
24.589 NC NC |
34.527 NC NC |
-19.458 NC NC |
REVENUE ( Thousands of USD ) |
||||
|---|---|---|---|---|
| QUARTERS | 2005 | 2006 | 2007 | 2008 |
| Q1
Q2 Q3 Q4 |
2.915 2.676 1.227 1.028 |
6.465 6.855 7.267 7.056 |
7.422 10.576 6.690 9.752 |
1.307 0.613 |
| TOTAL | 7.846 | 27.643 | 34.440 | |
| EARNINGS PER SHARE ( USD ) |
||||
| QUARTERS | 2005 | 2006 | 2007 | 2008 |
| Q1
Q2 Q3 Q4 |
-0.240 -0.300 -0.360 -0.330 |
-0.210 -0.240 -0.190 -0.240 |
-0.260 -0.220 -0.290 -0.260 |
-0.470 -0.540 |
| TOTAL | -1.230 | -0.880 | -1.030 | |